Only Sunlighten saunas are backed by clinical research that shows a reduction in systolic and diastolic blood pressure. Both are key factors in maintaining a healthy heart.
As part of a blood pressure therapy program, regular use of a Sunlighten infrared sauna is good for your heart! In the U.S. alone, one in three adults suffers from heart disease, stroke or some other form of cardiovascular disease in their lifetime. High blood pressure increases your risk of getting heart disease, kidney disease or serious stroke.
Only Sunlighten saunas have been clinically determined to provide one of the best, natural ways to lower blood pressure. In a 2005 clinical study by the University of Missouri Kansas City, Sunlighten’s Solocarbon heaters were shown to lower blood pressure through a program of 30 minute infrared sauna session 3 times per week. The study concluded that Sunlighten infrared sauna therapy dilated blood vessels and reduced the volume of their inner lining, thus increasing circulation to promote healthy blood pressure.1 SEE STUDY.
Additionally, a Japanese study published in the October 2008 issue of The Journal of Cardiology examined the clinical effectiveness and safety of infrared blood pressure therapy, as compared to standard therapies for patients with chronic heart failure. The report concluded that far-infrared sauna therapy is both safe and effective at improving clinical symptoms and cardiac function as well as decreasing cardiac size in chronic heart failure patients. Repeated infrared sauna treatments improved impaired blood vessel functions in patients with high blood pressure, diabetes and high cholesterol. This suggests a preventive role for infrared sauna use for arteriosclerosis.2
1 Becky Edwards, M.D., Heather Kort D.O, Faculty Staff Advisor: Dr. John Foxworth, PharmD. A Study of the Health Benefits of Far Infrared Sauna Therapy - Conducted by the University of Missouri, Kansas City, 2005.
2 Dr. Masakazu Imamura, MD, et al. Repeated Thermal Therapy Improves Impaired Vascular Endothelial Function in Patients With Coronary Risk Factors. Vol. 38, No. 4, 2001. Journal of American College of Cardiology: pp 1083-1088.